Tejnaksh Healthcare opened lower at ₹13.20, compared with its previous close of ₹13.25. In the last trading session on 12 Nov 2026, the stock traded between ₹13.00 and ₹13.20, with an average traded price of ₹13.16. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Tejnaksh Healthcare is now worth
₹ 1,091.00
Resulting in a loss of
₹ 8,909.00 (89.09%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.05 (-0.38%)
Day High
₹13.20
Day Low
₹13.00
Day Open
₹13.20
Prev Close
₹13.25
Volume
131
Value Traded
₹0.00 Cr
1W Return
2.88%
1M Return
8.46%
3M Return
-2.94%
6M Return
-17.14%
1Y Return
-23.03%
Market Cap (₹ Cr.)
27
PE Ratio
21.70
PB Ratio
0.99
Dividend Yield
-
ROE
4.27%
ROCE
5.92%
Book Value (₹)
13.36
Face Value (₹)
5.00
EPS (TTM)
0.13
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.88%
6 Weeks
-
1 Month
8.46%
3 Months
-2.94%
9 Months
-9.84%
Tejnaksh Healthcare Q2FY27 Results: Net profit up 92% YoY to ₹63.85 lakh
Consolidated net profit rose 92.4% YoY to ₹63.85 lakh in Q2FY27. Revenue from operations increased 5.8% YoY to ₹315.07 lakh. Employee benefits expense declined significantly to ₹24.80 lakh from ₹41.35 lakh YoY. Company remains debt-free with zero borrowings as of September 30, 2026. Basic EPS improved to ₹0.28 from ₹0.17 in the corresponding quarter last year.
TodayTejnaksh Healthcare Pflow device gets scientific validation in urology journal
Pflow™ device validated in Indian Journal of Urology. Study covered 372 patients across two tertiary centers. Device showed agreement with conventional gravimetric methods. Published paper features MD and Director as contributing authors.
19 days agoTejnaksh Healthcare passes all 4 resolutions at 19th AGM
All four resolutions passed unanimously at the 19th AGM held on September 29, 2026. Suhas Vasantrao Thorat re-appointed as Independent Director for a second term of 5 years. Total votes polled for financial statements and director re-appointments stood at 15,385,657.
1mo agoTejnaksh Healthcare sets Sept 29 AGM for director reappointment
Tejnaksh Healthcare schedules 19th AGM for September 29, 2026. Shareholders to reappoint Sanjay Khatal and Suhas Thorat as directors. Approval sought for related-party transactions totaling ₹100 lakh per entity. Remote e-voting opens on September 26 and closes on September 28.
2mo agoTejnaksh Healthcare FY26 profit falls 47% on lower revenue
Tejnaksh Healthcare reported a 47.4% decline in consolidated net profit to ₹118.11 lakh for FY26, driven by a 16.3% drop in revenue to ₹1,078.69 lakh. The Board approved the audited results and decided not to proceed with the proposed Rights Issue due to postponed expansion plans.
5mo agoTejnaksh Healthcare board to meet on May 30 for Q4FY26 results
Tejnaksh Healthcare Limited will hold a board meeting on May 30, 2026, to approve the audited financial results for the quarter and fiscal year ended March 31, 2026. The trading window is closed until 48 hours post-results declaration.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹8,579.50 | +0.76% | ₹1,23,360.05 | 52.40 | +14.42% | |
| ₹943.15 | -0.33% | ₹91,797.76 | 66.60 | -14.54% | |
| ₹685.65 | +1.35% | ₹90,188.84 | 98.20 | +16.21% | |
| ₹722.35 | -1.84% | ₹62,965.26 | 113.80 | +6.02% | |
| ₹762.00 | +0.26% | ₹57,527.81 | 54.00 | -21.39% | |
| ₹1,444.00 | +0.30% | ₹38,825.09 | 63.10 | +23.02% | |
| ₹1,852.40 | +0.67% | ₹37,855.80 | 43.70 | +5.30% | |
| ₹1,978.40 | -1.51% | ₹33,207.21 | 57.30 | +28.44% | |
| ₹723.80 | -0.48% | ₹30,400.07 | 155.10 | +5.30% | |
| ₹447.90 | +0.02% | ₹18,080.34 | 97.10 | -32.53% | |
| ₹554.50 | +0.59% | ₹17,579.10 | 85.10 | +8.49% | |
| ₹668.40 | +0.35% | ₹16,106.22 | 39.00 | +31.37% |
An investment of ₹10,000 made 5 years ago in Tejnaksh Healthcare is now worth
₹ 1,091.00
Resulting in a loss of
₹ 8,909.00 (89.09%)
Note: Past profits do not guarantee future returns.
